Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nobuyasu Enami"'
Late recurrence in patients with non‐muscle‐invasive bladder cancer after 5‐year cancer‐free periods
Autor:
Yurie Hirata, Madoka Higuchi, Takahiro Osawa, Shiro Hinotsu, Toru Harabayashi, Tango Mochizuki, Nobuyasu Enami, Osamu Nounaka, Yuichiro Shinno, Hiroshi Kikuchi, Ryuji Matsumoto, Takashige Abe, Sachiyo Murai, Nobuo Shinohara
Publikováno v:
International Journal of Urology. 29:1140-1146
There is no consensus about the follow-up schedule after 5-year cancer-free periods. In this study, we aimed to elucidate the risk factors for the recurrence in patients with non-muscle-invasive bladder cancer who remained cancer free for more than 5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::747f87a66d6c95504b519b1912af3ac2
https://doi.org/10.1111/iju.14936
https://doi.org/10.1111/iju.14936
Autor:
Tango Mochizuki, Takashige Abe, Toru Harabayashi, Sachiyo Murai, Shiro Hinotsu, Yuichiro Shinno, Hiroshi Kikuchi, Madoka Higuchi, Takahiro Osawa, Ryuji Matsumoto, Osamu Nounaka, Yurie Hirata, Nobuyasu Enami, Nobuo Shinohara
Publikováno v:
Journal of Urology. 203
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1d764531ae6dfe911fe3d3fbdb50b56
https://doi.org/10.1097/ju.0000000000000952.014
https://doi.org/10.1097/ju.0000000000000952.014
Autor:
Nobuyasu Enami, Tatsurou Takahashi, Kunihiro Ishihara, Ken Morita, Seiji Ohira, Noritomo Itami
Publikováno v:
Nihon Toseki Igakkai Zasshi. 34:1415-1419
症例は55歳男性. 慢性糸球体腎炎にて血液透析を3.5年施行中, 定期検査のCTにて両側腎に小径腫瘍を1個ずつ認めた. 遠隔転移を認めず, ハンドアシスト腹腔鏡下両側腎摘出術を施行した.長
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e84d4e9af410b43ac44b3d7badd0488a
https://doi.org/10.4009/jsdt.34.1415
https://doi.org/10.4009/jsdt.34.1415
Autor:
Masaki Togashi, Nobuyasu Enami, Tomohiko Koyanagi, Hitoshi Chiba, Motoyoshi Tanaka, Takayoshi Demura, Nobuo Ohashi, Katsuya Nonomura, Nobuo Shinohara
Publikováno v:
Cancer. 77:1137-1143
BACKGROUND Prostate specific antigen (PSA) is the most useful marker for prostate carcinoma (CaP). However, the sensitivity and specificity for PSA are not sufficient for the diagnosis of organ-confined prostate carcinoma. Recent studies have reveale
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7faa0c4cf11be9d005b6ee6404ca6b7
https://doi.org/10.1002/(sici)1097-0142(19960315)77:6<1137::aid-cncr20>3.0.co
https://doi.org/10.1002/(sici)1097-0142(19960315)77:6<1137::aid-cncr20>3.0.co